twoXAR Announces Preclinical Proof-of-Concept Data on Type 2 Diabetes Candidate

PALO ALTO, Calif.–(BUSINESS WIRE)–#AI–twoXAR demonstrates the power of artificial intelligence-enabled approaches in accelerating early-stage drug discovery in type II diabetes
Source: BusinessWire-Primary

twoXAR Announces Preclinical Proof-of-Concept Data on Type 2 Diabetes Candidate